236 related articles for article (PubMed ID: 26687339)
1. Effects of Combination of Ezetimibe and Rosuvastatin on Coronary Artery Plaque in Patients with Coronary Heart Disease.
Wang X; Zhao X; Li L; Yao H; Jiang Y; Zhang J
Heart Lung Circ; 2016 May; 25(5):459-65. PubMed ID: 26687339
[TBL] [Abstract][Full Text] [Related]
2. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin.
Ran D; Nie HJ; Gao YL; Deng SB; Du JL; Liu YJ; Jing XD; She Q
Int J Cardiol; 2017 May; 235():49-55. PubMed ID: 28291622
[TBL] [Abstract][Full Text] [Related]
4. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease.
Masuda J; Tanigawa T; Yamada T; Nishimura Y; Sasou T; Nakata T; Sawai T; Fujimoto N; Dohi K; Miyahara M; Nishikawa M; Nakamura M; Ito M
Int Heart J; 2015 May; 56(3):278-85. PubMed ID: 25902885
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
[TBL] [Abstract][Full Text] [Related]
7. Pathologic Intimal Thickening Plaque Phenotype: Not as Innocent as Previously Thought. A Serial 3D Intravascular Ultrasound Virtual Histology Study.
Kovarnik T; Chen Z; Wahle A; Zhang L; Skalicka H; Kral A; Lopez JJ; Horak J; Sonka M; Linhart A
Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):25-33. PubMed ID: 27615562
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.
Han SH; Chung WJ; Kang WC; Lee K; Park YM; Shin MS; Ahn TH; Choi IS; Shin EK
Int J Cardiol; 2012 Jul; 158(2):217-24. PubMed ID: 21295363
[TBL] [Abstract][Full Text] [Related]
9. Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: Assessment with serial coronary CT angiography.
Auscher S; Heinsen L; Nieman K; Vinther KH; Løgstrup B; Møller JE; Broersen A; Kitslaar P; Lambrechtsen J; Egstrup K
Atherosclerosis; 2015 Aug; 241(2):579-87. PubMed ID: 26115069
[TBL] [Abstract][Full Text] [Related]
10. Impact of statin-ezetimibe combination on coronary atheroma plaque in patients with and without chronic kidney disease - Sub-analysis of PRECISE-IVUS trial.
Fujisue K; Nagamatsu S; Shimomura H; Yamashita T; Nakao K; Nakamura S; Ishihara M; Matsui K; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Sakamoto K; Izumiya Y; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
Int J Cardiol; 2018 Oct; 268():23-26. PubMed ID: 29925472
[TBL] [Abstract][Full Text] [Related]
11. Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome.
Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Kim N; Eo JS; Kim JW; Lee CW
J Cardiovasc Transl Res; 2020 Dec; 13(6):900-907. PubMed ID: 32367340
[TBL] [Abstract][Full Text] [Related]
12. Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation.
Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee CW
BMC Cardiovasc Disord; 2019 Aug; 19(1):201. PubMed ID: 31426749
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
[TBL] [Abstract][Full Text] [Related]
14. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome.
Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y
Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
[TBL] [Abstract][Full Text] [Related]
16. Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study.
Kwon TG; Jang AY; Kim SW; Hong YJ; Bae JH; Lee SY; Kim SH; Han SH
Trials; 2020 Apr; 21(1):353. PubMed ID: 32321551
[TBL] [Abstract][Full Text] [Related]
17. Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.
Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Am J Cardiol; 2010 Nov; 106(9):1241-7. PubMed ID: 21029819
[TBL] [Abstract][Full Text] [Related]
18. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
[TBL] [Abstract][Full Text] [Related]
19. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.
Park SJ; Kang SJ; Ahn JM; Chang M; Yun SC; Roh JH; Lee PH; Park HW; Yoon SH; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Han KH; Park SW
J Am Coll Cardiol; 2016 Apr; 67(15):1772-1783. PubMed ID: 27081016
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.
Thondapu V; Kurihara O; Yonetsu T; Russo M; Kim HO; Lee H; Soeda T; Minami Y; Jang IK
Am J Cardiol; 2019 May; 123(10):1565-1571. PubMed ID: 30851941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
